Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein
- PMID: 11193794
- DOI: 10.1111/j.1749-6632.2000.tb05554.x
Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein
Abstract
A central challenge of research on Alzheimer's disease (AD) is to assemble the enormous body of scientific observations about the disorder, some of them seemingly in conflict with others, into a coherent and credible mechanism of pathogenesis. In this article, I attempt to synthesize the disparate findings on AD into a unified sequence that essentially begins with alterations in the production or clearance of the amyloid beta-protein (A beta). Mounting evidence from many laboratories supports an A beta accumulation in limbic and association cortices as the fundamental initiator of the disease, with attendant therapeutic implications.
Similar articles
-
Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.Acta Neuropathol. 2015 Feb;129(2):163-5. doi: 10.1007/s00401-015-1387-2. Acta Neuropathol. 2015. PMID: 25600324 No abstract available.
-
The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.Folia Neuropathol. 2009;47(4):289-99. Folia Neuropathol. 2009. PMID: 20054780 Review.
-
Alzheimer's disease: Mental plaque removal.Nature. 2003 May 22;423(6938):392-3. doi: 10.1038/423392a. Nature. 2003. PMID: 12761533 No abstract available.
-
[The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].Rinsho Byori. 2013 Nov;61(11):1060-9. Rinsho Byori. 2013. PMID: 24450113 Review. Japanese.
-
Power tools for Alzheimer's disease - an electrochemical preamp for Aβ.J Neurochem. 2012 Jul;122(2):231-2. doi: 10.1111/j.1471-4159.2012.07730.x. J Neurochem. 2012. PMID: 22409410 No abstract available.
Cited by
-
Impact of Angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series.Arch Neurol. 2012 Dec;69(12):1632-8. doi: 10.1001/archneurol.2012.1010. Arch Neurol. 2012. PMID: 22964777 Free PMC article.
-
Calpain dysregulation in Alzheimer's disease.ISRN Biochem. 2012 Oct 16;2012:728571. doi: 10.5402/2012/728571. eCollection 2012. ISRN Biochem. 2012. PMID: 25969760 Free PMC article. Review.
-
Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.Pharm Res. 2004 Aug;21(8):1313-30. doi: 10.1023/b:pham.0000036905.82914.8e. Pharm Res. 2004. PMID: 15359566 Review.
-
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease.Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5161-6. doi: 10.1073/pnas.0600948103. Epub 2006 Mar 20. Proc Natl Acad Sci U S A. 2006. PMID: 16549764 Free PMC article.
-
Characterization of Alzheimer's Disease Using Ultra-high b-values Apparent Diffusion Coefficient and Diffusion Kurtosis Imaging.Aging Dis. 2019 Oct 1;10(5):1026-1036. doi: 10.14336/AD.2018.1129. eCollection 2019 Oct. Aging Dis. 2019. PMID: 31595200 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical